{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Leptotrichia : Questions médicales les plus fréquentes",
"headline": "Leptotrichia : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Leptotrichia : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Leptotrichia"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Bâtonnets à Gram négatif anaérobies droits, incurvés et spiralés",
"url": "https://questionsmedicales.fr/mesh/D016965",
"about": {
"@type": "MedicalCondition",
"name": "Bâtonnets à Gram négatif anaérobies droits, incurvés et spiralés",
"code": {
"@type": "MedicalCode",
"code": "D016965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.440.425.410"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Leptotrichia",
"alternateName": "Leptotrichia",
"code": {
"@type": "MedicalCode",
"code": "D045183",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "José Carlos Mora-Palma",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Carlos%20Mora-Palma",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Gestión Clínica de Obstetricia y Ginecología, Instituto de Investigación Biosanitaria de Granada, Hospital Universitario Virgen de las Nieves, Granada, Spain."
}
},
{
"@type": "Person",
"name": "Antonio Jesús Rodríguez-Oliver",
"url": "https://questionsmedicales.fr/author/Antonio%20Jes%C3%BAs%20Rodr%C3%ADguez-Oliver",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Gestión Clínica de Obstetricia y Ginecología, Instituto de Investigación Biosanitaria de Granada, Hospital Universitario Virgen de las Nieves, Granada, Spain."
}
},
{
"@type": "Person",
"name": "José María Navarro-Marí",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Mar%C3%ADa%20Navarro-Mar%C3%AD",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Microbiología, Instituto de Investigación Biosanitaria de Granada, Hospital Universitario Virgen de las Nieves, Avenida de las Fuerzas Armadas, 2, 18012, Granada, Spain."
}
},
{
"@type": "Person",
"name": "José Gutiérrez-Fernández",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Guti%C3%A9rrez-Fern%C3%A1ndez",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Microbiología, Instituto de Investigación Biosanitaria de Granada, Hospital Universitario Virgen de las Nieves, Avenida de las Fuerzas Armadas, 2, 18012, Granada, Spain. josegf@go.ugr.es."
}
},
{
"@type": "Person",
"name": "Matthew C Johnson",
"url": "https://questionsmedicales.fr/author/Matthew%20C%20Johnson",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35820290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.preghy.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cells.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37359546",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1200725"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lipopolysaccharides and outer membrane proteins as main structures involved in complement evasion strategies of non-typhoidal Salmonella strains.",
"datePublished": "2022-08-20",
"url": "https://questionsmedicales.fr/article/35998438",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.molimm.2022.08.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pitfalls in complement analysis: A systematic literature review of assessing complement activation.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36330514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1007102"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients.",
"datePublished": "2023-05-08",
"url": "https://questionsmedicales.fr/article/37244049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2023.154519"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Bactéries à Gram négatif",
"item": "https://questionsmedicales.fr/mesh/D006090"
},
{
"@type": "ListItem",
"position": 4,
"name": "Bactéries anaérobies à Gram négatif",
"item": "https://questionsmedicales.fr/mesh/D006089"
},
{
"@type": "ListItem",
"position": 5,
"name": "Bâtonnets à Gram négatif anaérobies droits, incurvés et spiralés",
"item": "https://questionsmedicales.fr/mesh/D016965"
},
{
"@type": "ListItem",
"position": 6,
"name": "Leptotrichia",
"item": "https://questionsmedicales.fr/mesh/D045183"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Leptotrichia - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Leptotrichia",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Leptotrichia",
"description": "Comment diagnostiquer une infection par Leptotrichia ?\nQuels tests sont utilisés pour identifier Leptotrichia ?\nLeptotrichia peut-elle être détectée dans des prélèvements ?\nQuels symptômes indiquent une infection par Leptotrichia ?\nLes tests sanguins sont-ils utiles pour Leptotrichia ?",
"url": "https://questionsmedicales.fr/mesh/D045183?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Leptotrichia",
"description": "Quels sont les symptômes d'une infection buccale par Leptotrichia ?\nLeptotrichia peut-elle causer des infections vaginales ?\nY a-t-il des symptômes systémiques associés ?\nLes infections par Leptotrichia sont-elles asymptomatiques ?\nComment se manifeste une infection par Leptotrichia dans la bouche ?",
"url": "https://questionsmedicales.fr/mesh/D045183?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Leptotrichia",
"description": "Comment prévenir les infections par Leptotrichia ?\nLes probiotiques aident-ils à prévenir les infections par Leptotrichia ?\nFaut-il éviter certains aliments pour prévenir Leptotrichia ?\nLes visites régulières chez le dentiste sont-elles importantes ?\nLe lavage des mains aide-t-il à prévenir Leptotrichia ?",
"url": "https://questionsmedicales.fr/mesh/D045183?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Leptotrichia",
"description": "Quel est le traitement standard pour une infection par Leptotrichia ?\nLes antibiotiques sont-ils toujours efficaces contre Leptotrichia ?\nDes traitements alternatifs existent-ils pour Leptotrichia ?\nCombien de temps dure le traitement pour Leptotrichia ?\nLes infections par Leptotrichia nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D045183?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Leptotrichia",
"description": "Quelles complications peuvent survenir avec Leptotrichia ?\nLeptotrichia peut-elle causer des infections pulmonaires ?\nY a-t-il un risque de septicémie avec Leptotrichia ?\nLes infections par Leptotrichia peuvent-elles affecter le cœur ?\nQuelles sont les conséquences d'une infection non traitée ?",
"url": "https://questionsmedicales.fr/mesh/D045183?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Leptotrichia",
"description": "Quels sont les facteurs de risque pour une infection par Leptotrichia ?\nLes personnes âgées sont-elles plus à risque ?\nLe tabagisme augmente-t-il le risque d'infection ?\nLes patients diabétiques sont-ils plus vulnérables ?\nLes traitements immunosuppresseurs augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D045183?mesh_terms=Complement+Membrane+Attack+Complex&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Leptotrichia ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne et identification en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Leptotrichia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des techniques de biologie moléculaire comme PCR sont utilisés."
}
},
{
"@type": "Question",
"name": "Leptotrichia peut-elle être détectée dans des prélèvements ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être isolée à partir de prélèvements buccaux ou vaginaux."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Leptotrichia ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur, inflammation et écoulement anormal."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour Leptotrichia ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins ne sont généralement pas spécifiques pour Leptotrichia."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection buccale par Leptotrichia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement et mauvaise haleine."
}
},
{
"@type": "Question",
"name": "Leptotrichia peut-elle causer des infections vaginales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être associée à des vaginites et des infections vaginales."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme fièvre peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les infections par Leptotrichia sont-elles asymptomatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être asymptomatiques, surtout chez les porteurs sains."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une infection par Leptotrichia dans la bouche ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des ulcérations, des douleurs et des infections des gencives."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Leptotrichia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène buccale et vaginale aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les probiotiques aident-ils à prévenir les infections par Leptotrichia ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les probiotiques peuvent aider à équilibrer la flore microbienne, mais les données sont limitées."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments pour prévenir Leptotrichia ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et éviter les sucres excessifs peuvent aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les visites régulières chez le dentiste sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des visites régulières aident à détecter et prévenir les infections buccales."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir Leptotrichia ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le lavage des mains est essentiel pour prévenir la transmission de nombreuses infections."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour une infection par Leptotrichia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques appropriés selon la sensibilité."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils toujours efficaces contre Leptotrichia ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, car certaines souches peuvent être résistantes à certains antibiotiques."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils pour Leptotrichia ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme les probiotiques peuvent être envisagés, mais peu de données existent."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement pour Leptotrichia ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement dépend de la gravité de l'infection, généralement 7 à 14 jours."
}
},
{
"@type": "Question",
"name": "Les infections par Leptotrichia nécessitent-elles une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'infection; les cas graves peuvent nécessiter une hospitalisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Leptotrichia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections systémiques et des abcès dans les cas graves."
}
},
{
"@type": "Question",
"name": "Leptotrichia peut-elle causer des infections pulmonaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections pulmonaires peuvent survenir, surtout chez les immunodéprimés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de septicémie avec Leptotrichia ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans les cas graves, Leptotrichia peut entraîner une septicémie."
}
},
{
"@type": "Question",
"name": "Les infections par Leptotrichia peuvent-elles affecter le cœur ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des endocardites, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une infection non traitée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection non traitée peut entraîner des complications graves, y compris la mort."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour une infection par Leptotrichia ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent une mauvaise hygiène buccale, immunodépression et diabète."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'infections par Leptotrichia."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer la flore buccale et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les patients diabétiques sont-ils plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections par Leptotrichia."
}
}
]
}
]
}
We sought to determine if soluble levels of C5b-9, the terminal complement complex, correlate with end-organ injury in preeclampsia....
Project COPA (Complement and Preeclampsia in the Americas), a multi-center observational study in Colombia from 2015 to 2016, enrolled hypertensive pregnant women into four groups: chronic hypertensio...
C5b-9 concentrations in plasma and urine, using enzyme linked immunosorbent assays....
In total, 298 hypertensive participants were enrolled. Plasma and urine C5b-9 levels were measured in all participants and stratified by quartile (Q1-4), from lowest to highest C5b-9 concentration. Pa...
We identified a pattern of increased urine and low plasma C5b-9 levels in patients with preeclampsia and end-organ injury. Soluble C5b-9 levels may be used to identify complement-mediated end-organ in...
Polymorphisms in complement genes are risk-associated for age-related macular degeneration (AMD). Functional analysis revealed a common deficiency to control the alternative complement pathway by risk...
Collection of plasma from patients with wet AMD (n = 87: 62% female and 38% male; median age 77 years) and controls (n = 86: 39% female and 61% male; median age 58 years), grouped for risk factor smok...
Genotyping, measurement of TCC concentrations, ARPE-19 cell culture, Ca...
TCC concentration in plasma, intracellular free Ca...
TCC levels in the plasma of AMD patients were five times higher than in non-AMD controls but did not differ in plasma from carriers of the two risk alleles. Complement-evoked Ca...
TCC levels were higher in AMD patients but did not depend on genetic risk factors. The Ca...
Non-typhoidal Salmonella (NTS) infections pose a serious public health problem. In addition to the typical course of salmonellosis, an infection with Salmonella bacteria can often lead to parenteral i...
The complement system is an essential component of our innate defense and plays a vital role in the pathogenesis of many diseases. Assessment of complement activation is critical in monitoring both di...
We performed a systematic analysis of the current methods used to assess complement components and reviewed whether the identified studies performed their complement measurements according to the reco...
A literature search using the Pubmed/MEDLINE database was performed focusing on studies measuring the key complement components C3, C5 and/or their split products and/or the soluble variant of the ter...
A total of 92 out of 376 studies were selected for full-text analysis. Forty-five studies (49%) were identified as using the correct sample type and techniques for their complement analyses, while 25 ...
A substantial part of the reviewed studies did not use the appropriate sample type for assessing complement activation or did not mention which sample type was used. This deviation from the standardiz...
We explored the pathological changes and the activation of local complement system in COVID-19 pneumonia. Lung paraffin sections of COVID-19 infected patients were analyzed by HE (hematoxylin-eosin) s...
Myasthenia gravis is a neuromuscular disease associated with antibodies against components of the neuromuscular junction, most often against the acetylcholine receptor (AChR). Although several mechani...
Bacterial and mitochondrial DNA, sharing an evolutionary origin, act as danger-associated molecular patterns in infectious and sterile inflammation. They both contain immunomodulatory CpG motifs. Inte...
Atypical hemolytic uremic syndrome (aHUS) is a rare kidney disease caused by dysregulation of the complement alternative pathway. The complement dysregulation specifically leads to damage to the glome...
Endothelial cells were incubated with human test sera and stained with an anti-C5b-9 antibody to visualize and quantify complement depositions on the cells with immunofluorescence microscopy....
First, we showed that zymosan-activated sera resulted in increased endothelial C5b-9 depositions compared to normal human serum (NHS). The levels of C5b-9 depositions were similar between conditionall...
In conclusion, we demonstrate a robust and reliable model to adequately measure C5b-9-based complement deposition on human control and patient ciGMVECs. This model can be used to study the pathophysio...
Complement is involved in the pathogenesis of neuroimmune disease, but the detailed pathological roles of the complement pathway remain incompletely understood. Recently, eculizumab, a humanized anti-...
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction (NMJ) of skeletal muscle. Complement activation is one of the mechanisms by which anti-acetylcholine receptor (anti...
In this single-center, observational study of 45 patients with anti-AChR-antibody-positive generalized MG, serum concentrations of major components of the complement pathways, including C1q, C5, C5a, ...
The patients with MG exhibited lower serum levels of C5 (p = .0001) and higher serum levels of sC5b-9 (p = .004) compared with the control group. At about 6 months (range, 172-209 days) after the star...
Herein, we provide evidence for the activation of the classical complement pathway and its association with disease activity in anti-AChR-antibody-positive generalized MG....